?您的位置:對照品 > 標(biāo)準品 > dr標(biāo)準品 > |
|
|
產(chǎn)品基本信息 |
|
產(chǎn)品編號:N388602 |
產(chǎn)品名稱:Necrosulfonamide-d4 |
產(chǎn)品CAS:1795144-22-7 |
規(guī)格含量:10mg |
產(chǎn)品價格:面議 |
聯(lián)系我們: |
|
|
|
|
|
產(chǎn)品詳細介紹 |
標(biāo)準品編號: |
N388602 |
名稱: |
Necrosulfonamide-d4 |
別名: |
N-[4-[[(3-Methoxypyrazinyl)amino]sulfonyl](phenyl]-d4)-3-(5-nitro-2-thienyl)-2-propenamide; (E)-N-[4-[N-(3-methoxypyrazin-2-yl)sulfamoyl](phenyl-d4)]-3-(5-nitrothiophene-2-yl)acrylamide; |
CAS號: |
1795144-22-7 |
參考CAS號: |
類似: 432531-71-0 |
分子式: |
C??H??D?N?O?S? |
外觀: |
淡黃色固體 |
熔點: |
>200°C (dec.) |
分子量: |
465.5 |
儲存: |
Amber Vial, 冰箱, Under Inert Atmosphere |
溶解度: |
DMSO, Methanol |
種類: |
Standards; Isotopic Labeled Analogues; Enzyme Activators and Inhibitors; Pharmaceutical/API Drug Impurities/Metabolites; |
應(yīng)用: |
Labelled Necrosulfonamide. Necrosulfonamide specifically blocks necrosis downstream of receptor-interacting serine-threonine kinase 3 (RIP3) activation. RIP3 is a key signalling molecule in the programmed necrosis (necroptosis) pathway. |
參考文獻 |
|
|
|
|
|
|